To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL LIMITED - CHANGES TO THE BOARD OF DIRECTORS

Release Date: 26/07/2012 13:20
Code(s): MDC
Wrap Text
CHANGES TO THE BOARD OF DIRECTORS

MEDICLINIC INTERNATIONAL LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
Share Code: MDC
("Mediclinic" or "the company")

CHANGES TO THE BOARD OF DIRECTORS

The Board of Mediclinic (“the Board”) is pleased to announce the
appointment of Mr Alan Grieve (independent non-executive),
Ms Nandi Mandela (independent non-executive) and Mr Trevor
Petersen (non-executive) as directors of the company with effect
from the date of the company’s next board meeting, 13 September
2012.

Mr Alan Grieve is a chartered accountant (Scotland) and the
Director of Corporate Affairs of Richemont SA. He is also the
Chief Executive Officer of Reinet Investments Manager SA and
Reinet Fund Manager SA, as well as a director of various
subsidiary companies of Remgro Limited and Venfin Limited.
Mr Grieve was also appointed by the Board as a member of the
company’s Audit and Risk Committee and Investment Sub-committee.

Ms Nandi Mandela is the Director of Development and Marketing of
Linda Masinga & Associates, a town planning and consultancy firm.
She is also the founder and director of New Ground Investments
(Pty) Ltd, a property development company and Natholigugu
Investment (Pty) Ltd, a women owned investment company focusing on
property development. Ms Mandela was also appointed by the Board
as a member of the company’s Social and Ethics Committee.

Mr Trevor Peterson is a chartered accountant (South Africa) and
former managing partner of the Cape Town office of
PricewaterhouseCoopers Inc. (“PwC”). He is also a former chairman
of PwC Western Cape and the South African Institute of Chartered
Accountants. He currently serves on the University of Cape Town
Council and is also a director of Petmin Limited. Mr Petersen was
also appointed by the Board as a member of the company’s
Remuneration and Nominations Committee. Mr Petersen is currently
not regarded as independent in terms of the JSE Listings
Requirements due to him being a partner of the company’s external
auditors, PwC, within the last three years. This three year period
will expire at the end of December 2012, whereafter Mr Petersen
will be regarded as independent and also be appointed to the Audit
and Risk Committee.

As previously announced, Mr Joe Cohen (non-executive), Ms Zodwa
Manase (independent non-executive), Dr Mamphela Ramphele (non-
executive) and Prof Wynand van der Merwe (independent non-
executive) will retire as directors of the company at the
company’s annual general meeting to be held today, 26 July 2012 at
15:00 and have not made themselves available for re-election. The
Board is thankful for their valuable contribution as directors.

Stellenbosch
26 July 2012

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 26/07/2012 01:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story